1. An Endocrinology Clinic in Dyslipidemia

2. Case 1: A Patient With Diabetes

3. Case 2: More Advanced Disease in a Patient With Diabetes

4. Prevalence of Chronic Conditions in T2D

7. Causes of Death Among Patients With Type 2 Diabetes

8. Prevention of CVD in T2D: CARDS Trial

11. Treatment of Dyslipidemia in Diabetes

12. Statin LDL-C Lowering Efficacy

13. Lipid Effects of Drug Classes in Dyslipidemia

14. ACCORD: Statin + Fenofibrate in T2D

15. AIM-HIGH: Statin + Niacin

16. Ezetimibe in Patient with Diabetes

17. Safety of Very Low LDL-C Levels: Insights From the JUPITER Trial

18. ODYSSEY LONG-TERM Adverse Events in Patients With 2 Consecutive LDL-C < 25 mg/dL

19. LDL-C Lowering in Diabetes

20. Safety of PCSK9 Inhibitors in T2D

22. Abbreviations

23. Abbreviations (cont)

24. Abbreviations (cont)